Abstract
Knowledge about temporal associations for screen-detected gallstone disease and cardiovascular disease is limited. The objective of this study was to determine if screen-detected gallstones or cholecystectomy was associated with development of cardiovascular disease. A cohort study of three randomly selected groups from the general population of Copenhagen was performed. Participants (n = 5928) were examined 1982–1992 and underwent abdominal ultrasound examination to detect gallstone disease and were not informed of their gallstone status. Participants were followed up for occurrence of cardiovascular disease through nationwide registers until December 2014. Multivariable Cox regression analyses were performed including traditional cardiovascular disease risk factors and apolipoprotein E genotype. Gallstone disease was identified in 10% (591/5928) of participants at baseline of whom 6.8% had gallstones and 3.2% had cholecystectomy. The study population was followed for a period of 32 years with only 1% lost to follow-up. Gallstone disease was associated with all cardiovascular disease (hazard ratio (HR) 1.36, 95% confidence interval (CI) [1.17;1.59]) and to the subgroups coronary artery (HR 1.34, 95% CI [1.10;1.64]), cerebrovascular (HR 1.22, 95% CI [0.97;1.52]), and peripheral artery disease (HR 1.57, 95% CI [1.15;2.13]). No differences in estimates were identified for gallstones detected at ultrasound or cholecystectomy. Adjustment did not change estimates substantially. Gallstone disease seems to be independently associated to cardiovascular disease. Associations cannot be explained through traditional cardiovascular disease risk factors, apolipoprotein E4 allele, or detection bias. Future studies should explore the link between gallstone and cardiovascular disease further and gut microbiota may be a candidate mechanism.
Similar content being viewed by others
References
Patterson HA. The association of gallstones and heart disease. Ann Surg. 1954;139(5):683–9.
Friedman G. The relationship between coronary heart disease and gallbladder disease. A critical review. Ann Intern Med. 1968;68:222–35.
Paul O, Lepper MH, Phelan WH, et al. A longitudinal study of coronary heart disease. Circulation. 1963;28:20–31.
Bortnichak EA, Freeman DH Jr, Ostfeld AM, et al. The association between cholesterol cholelithiasis and coronary heart disease in Framingham Massachusetts. Am J Epidemiol. 1985;121(1):19–30.
Olaiya MT, Chiou HY, Jeng JS, Lien LM, Hsieh FI. Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort study. PLoS ONE. 2013;8(10):e76448. doi:10.1371/journal.pone.0076448.
Wei CY, Chung TC, Chen CH, et al. Gallstone disease and the risk of stroke: a nationwide population-based study. J Stroke Cerebrovasc Dis. 2014;23(7):1813–20. doi:10.1016/j.jstrokecerebrovasdis.2014.04.024.
Lv J, Qi L, Yu C, et al. Gallstone disease and the risk of ischemic heart disease. Arterioscler Thromb Vasc Biol. 2015;35(10):2232–7. doi:10.1161/ATVBAHA.115.306043.
Wirth J, Giuseppe R, Wientzek A, et al. Presence of gallstones and the risk of cardiovascular diseases: the EPIC-Germany cohort study. Eur J Prev Cardiol. 2015;22(3):326–34. doi:10.1177/2047487313512218.
Zheng Y, Xu M, Li Y, et al. Gallstones and risk of coronary heart disease: prospective analysis of 270 000 men and women from 3 US cohorts and meta-analysis. Arterioscler Thromb Vasc Biol. 2016;36(9):1997–2003. doi:10.1161/ATVBAHA.116.307507.
Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology. 2011;140(2):508–16. doi:10.1053/j.gastro.2010.10.060.
Shabanzadeh DM, Sorensen LT, Jorgensen T. Gallstone disease and mortality: a cohort study. Int J Public Health. 2017;62(3):353–60. doi:10.1007/s00038-016-0916-7.
Diehl AK. Cholelithiasis and the insulin resistance syndrome. Hepatology. 2000;31(2):528–30. doi:10.1002/hep.510310238.
Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230–9. doi:10.1016/S0140-6736(06)69044-2.
Bennet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298(11):1300–11. doi:10.1001/jama.298.11.1300.
Xue P, Niu WQ, Jiang ZY, Zheng MH, Fei J. A meta-analysis of apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism for gallbladder stone disease. PLoS ONE. 2012;7(9):e45849. doi:10.1371/journal.pone.0045849.
Jorgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol. 1987;126(5):912–21.
Jorgensen T, Kay L, Schultz-Larsen K. The epidemiology of gallstones in a 70-year-old Danish population. Scand J Gastroenterol. 1990;25(4):335–40.
Jorgensen T. Treatment of gallstone patients. A Health Technology Assessment: Danish Institute for Health Technology Assessment and National Institute of Public Health. 2000.
Jensen KH, Jorgensen T. Incidence of gallstones in a Danish population. Gastroenterology. 1991;100(3):790–4.
Shabanzadeh DM, Sorensen LT, Jorgensen T. Determinants for gallstone formation—a new data cohort study and a systematic review with meta-analysis. Scand J Gastroenterol. 2016;51(10):1239–48. doi:10.1080/00365521.2016.1182583.
Shabanzadeh DM, Jorgensen T, Linneberg A, Sorensen LT, Skaaby T. Vitamin D and gallstone disease—a population-based study. Endocrine. 2016;54(3):818–25. doi:10.1007/s12020-016-1113-4.
Shabanzadeh DM, Sørensen LT, Jørgensen T. Abdominal symptoms and incident gallstones in a population unaware of gallstone status. Can J Gastroenterol Hepatol. 2016;2016:9730687. doi:10.1155/2016/9730687.
Shabanzadeh DM, Sorensen LT, Jorgensen T. A prediction rule for risk stratification of incidentally discovered gallstones: results from a large cohort study. Gastroenterology. 2016;150(1):156–67. doi:10.1053/j.gastro.2015.09.002.
Shabanzadeh DM, Sorensen LT, Jorgensen T. Which abdominal symptoms are associated with clinical events in a population unaware of their gallstones? A cohort study. J Gastrointest Surg. 2017;21(5):831–9. doi:10.1007/s11605-016-3349-y.
Shabanzadeh DM, Sorensen LT, Jorgensen T. Determinants for clinical events in gallstone carriers unaware of their gallstones. J Gastroenterol Hepatol. 2017;32(3):721–6. doi:10.1111/jgh.13531.
Shabanzadeh DM, Sorensen LT, Jorgensen T. Association between screen-detected gallstone disease and cancer in a cohort study. Gastroenterology. 2017;. doi:10.1053/j.gastro.2017.02.013.
Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–3. doi:10.1177/1403494811401482.
Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health. 2011;39(Suppl. 7):26–9. doi:10.1177/1403494811399958.
Schmidt M, Pedersen L, Sorensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–9. doi:10.1007/s10654-014-9930-3.
Osler M, Helms Andreasen A, Heitmann B, et al. Food intake patterns and risk of coronary heart disease: a prospective cohort study examining the use of traditional scoring techniques. Eur J Clin Nutr. 2002;56(7):568–74. doi:10.1038/sj.ejcn.1601360.
Saltin B, Grimby G. Physiological analysis of middle-aged and old former athletes—comparison with still active athletes of same ages. Circulation. 1968;38(6):1104–15.
Jorgensen T. Gallstones in a Danish population: familial occurrence and social factors. J Biosoc Sci. 1988;20(1):111–20.
von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7. doi:10.1016/S0140-6736(07)61602-X.
Malik AA, Wani ML, Tak SI, Irshad I, Ul-Hassan N. Association of dyslipidaemia with cholilithiasis and effect of cholecystectomy on the same. Int J Surg. 2011;9(8):641–2. doi:10.1016/j.ijsu.2011.08.003.
Amigo L, Husche C, Zanlungo S, et al. Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int. 2011;31(1):52–64. doi:10.1111/j.1478-3231.2010.02361.x.
Ioannou GN. Cholelithiasis, cholecystectomy, and liver disease. Am J Gastroenterol. 2010;105(6):1364–73. doi:10.1038/ajg.2009.737.
Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol. 2013;108(6):952–8. doi:10.1038/ajg.2013.70.
Jiang ZY, Sheng X, Xu CY, et al. Gallbladder gallstone disease is associated with newly diagnosed coronary artery atherosclerotic disease: a cross-sectional study. PLoS ONE. 2013;8(9):e75400. doi:10.1371/journal.pone.0075400.
Lonardo A, Lombardini S, Scaglioni F, et al. Fatty liver, carotid disease and gallstones: a study of age-related associations. World J Gastroenterol WJG. 2006;12(36):5826–33.
Mendez-Sanchez N, Zamora-Valdes D, Flores-Rangel JA, et al. Gallstones are associated with carotid atherosclerosis. Liver Int. 2008;28(3):402–6. doi:10.1111/j.1478-3231.2007.01632.x.
Kim JH, Ryoo JG, Lee JW, Kim JH. Gallstones are associated with intima-media thickness of common carotid arteries in men. Korean J Fam Med. 2014;35(3):136–42. doi:10.4082/kjfm.2014.35.3.136.
Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290(5497):1771–5.
Buch S, Schafmayer C, Volzke H, et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet. 2007;39(8):995–9. doi:10.1038/ng2101.
Jiang ZY, Cai Q, Chen EZ. Association of three common single nucleotide polymorphisms of ATP binding cassette G8 gene with gallstone disease: a meta-analysis. PLoS ONE. 2014;9(1):e87200. doi:10.1371/journal.pone.0087200.
Marton KI, Doubilet P. How to image the gallbladder in suspected cholecystitis. Ann Intern Med. 1988;109(9):722–9.
Wells JE, Berr F, Thomas LA, Dowling RH, Hylemon PB. Isolation and characterization of cholic acid 7α-dehydroxylating fecal bacteria from cholesterol gallstone patients. J Hepatol. 2000;32(1):4–10.
Tilg H. A gut feeling about thrombosis. N Engl J Med. 2016;374(25):2494–6. doi:10.1056/NEJMcibr1604458.
Acknowledgements
This study was supported financially by the Faculty of Health and Medical Sciences at the University of Copenhagen. We would like to thank Anja Lykke Madsen and Gert Mehl Virenfeldt for extracting data from the included databases and Rikke Kart Jacobsen for statistical supervision.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Shabanzadeh, D.M., Skaaby, T., Sørensen, L.T. et al. Screen-detected gallstone disease and cardiovascular disease. Eur J Epidemiol 32, 501–510 (2017). https://doi.org/10.1007/s10654-017-0263-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-017-0263-x